| Primary |
| Cardiac Failure Chronic |
12.8% |
| Hypertension |
12.3% |
| Drug Use For Unknown Indication |
11.2% |
| Cardiac Failure Congestive |
10.7% |
| Product Used For Unknown Indication |
10.7% |
| Cardiac Failure |
9.6% |
| Cardiovascular Disorder |
6.4% |
| Oedema |
4.3% |
| Diuretic Therapy |
3.7% |
| Fluid Retention |
2.7% |
| Osteoarthritis |
2.7% |
| Atrial Fibrillation |
2.1% |
| Pneumonia |
2.1% |
| Pulmonary Embolism |
2.1% |
| Angiopathy |
1.1% |
| Ascites |
1.1% |
| Cardiac Disorder |
1.1% |
| Coronary Artery Disease |
1.1% |
| Dyspnoea |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
|
| Renal Failure Acute |
19.1% |
| Medication Error |
13.2% |
| Burning Sensation |
5.9% |
| Syncope |
5.9% |
| Vomiting |
5.9% |
| Gout |
4.4% |
| Hypokalaemia |
4.4% |
| Renal Disorder |
4.4% |
| Renal Failure |
4.4% |
| Shock |
4.4% |
| Atrial Fibrillation |
2.9% |
| Blood Urea Increased |
2.9% |
| Completed Suicide |
2.9% |
| Dehydration |
2.9% |
| Malaise |
2.9% |
| Pharmaceutical Product Complaint |
2.9% |
| Sinus Headache |
2.9% |
| Therapeutic Agent Toxicity |
2.9% |
| Wrong Drug Administered |
2.9% |
| Angioedema |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
50.5% |
| Cardiac Failure |
12.0% |
| Hypertension |
6.8% |
| Cardiovascular Disorder |
4.3% |
| Pneumonia |
4.0% |
| Pulmonary Embolism |
3.4% |
| Drug Use For Unknown Indication |
3.2% |
| Cardiac Failure Chronic |
2.9% |
| Osteoarthritis |
2.6% |
| Atrial Fibrillation |
1.6% |
| Lupus Nephritis |
1.3% |
| Rheumatoid Arthritis |
1.1% |
| Prophylaxis |
1.0% |
| Hypothyroidism |
0.9% |
| Ill-defined Disorder |
0.8% |
| Gout |
0.7% |
| Staphylococcal Infection |
0.7% |
| Multiple Myeloma |
0.7% |
| Oedema Peripheral |
0.7% |
| Blood Cholesterol Increased |
0.6% |
|
| Renal Failure Acute |
18.5% |
| Renal Failure |
11.9% |
| Shock |
6.5% |
| Temporal Arteritis |
6.5% |
| Completed Suicide |
6.0% |
| Therapeutic Agent Toxicity |
5.4% |
| Medication Error |
4.2% |
| Oedema Peripheral |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Syncope |
3.6% |
| Urinary Tract Infection |
3.6% |
| Vomiting |
3.6% |
| Oedema |
3.0% |
| Overdose |
3.0% |
| Skin Discolouration |
3.0% |
| Tachypnoea |
3.0% |
| Thrombocytopenia |
3.0% |
| Toxic Epidermal Necrolysis |
3.0% |
| Unresponsive To Stimuli |
3.0% |
| Agranulocytosis |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.6% |
| Drug Use For Unknown Indication |
18.2% |
| Hypertension |
5.9% |
| Atrial Fibrillation |
3.7% |
| Pain |
3.6% |
| Cardiac Failure |
3.0% |
| Diabetes Mellitus |
2.6% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Prophylaxis |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Pulmonary Arterial Hypertension |
1.8% |
| Depression |
1.7% |
| Cardiac Disorder |
1.7% |
| Osteoporosis |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Blood Cholesterol Increased |
1.1% |
| Pulmonary Hypertension |
1.1% |
| Cardiac Failure Congestive |
1.1% |
| Oedema |
1.1% |
|
| Vomiting |
10.5% |
| Death |
9.4% |
| Rhabdomyolysis |
8.0% |
| Weight Increased |
7.3% |
| Weight Decreased |
6.2% |
| Renal Failure Acute |
6.1% |
| Pneumonia |
5.7% |
| Renal Failure |
5.4% |
| Syncope |
4.6% |
| Urinary Tract Infection |
4.6% |
| Sepsis |
3.9% |
| Thrombocytopenia |
3.8% |
| Cardiac Failure |
3.6% |
| Dyspnoea |
3.5% |
| Gastrointestinal Haemorrhage |
3.2% |
| Oedema Peripheral |
3.2% |
| International Normalised Ratio Increased |
2.8% |
| Myocardial Infarction |
2.8% |
| Renal Impairment |
2.7% |
| White Blood Cell Count Increased |
2.6% |
|
| Interacting |
| Cardiac Failure |
38.5% |
| Product Used For Unknown Indication |
36.9% |
| Drug Use For Unknown Indication |
6.2% |
| Tachycardia |
6.2% |
| Atrial Fibrillation |
4.6% |
| Cardiac Failure Congestive |
3.1% |
| Hypertension |
3.1% |
| Oedema Peripheral |
1.5% |
|
| Hyperkalaemia |
14.3% |
| Renal Failure Acute |
14.3% |
| Shock |
14.3% |
| Acute Prerenal Failure |
7.1% |
| Cardiogenic Shock |
7.1% |
| Diarrhoea |
7.1% |
| Drug Interaction |
7.1% |
| Hypokalaemia |
7.1% |
| Nasal Disorder |
7.1% |
| Renal Failure |
7.1% |
| Visual Impairment |
7.1% |
|
